Allakos Inc (ALLK)

$1.35

Market is closed - opens 8 PM, 11 Nov 2024

Performance

  • $1.33
    $1.39
    $1.35
    downward going graph

    1.49%

    Downside

    Day's Volatility :4.51%

    Upside

    3.07%

    downward going graph
  • $0.54
    $3.41
    $1.35
    downward going graph

    60.37%

    Downside

    52 Weeks Volatility :84.29%

    Upside

    60.35%

    downward going graph

Returns

PeriodAllakos IncSector (Health Care)Index (Russel 2000)
3 Months
92.91%
-0.1%
0.0%
6 Months
7.14%
4.9%
0.0%
1 Year
-28.19%
16.3%
0.0%
3 Years
-98.56%
11.6%
-27.6%

Highlights

Market Capitalization
125.3M
Book Value
$0.95
Earnings Per Share (EPS)
-2.35
Wall Street Target Price
2.77
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-49.29%
Return On Equity TTM
-121.54%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-182.5M
Diluted Eps TTM
-2.35
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.54
EPS Estimate Next Year
-0.66
EPS Estimate Current Quarter
-0.33
EPS Estimate Next Quarter
-0.25

Analyst Recommendation

Buy
    53%Buy
    40%Hold
    6%Sell
Based on 15 Wall street analysts offering stock ratings for Allakos Inc(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
6
6
6
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 105.19%

Current $1.35
Target $2.77

Technicals Summary

Sell

Neutral

Buy

Allakos Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Allakos Inc
Allakos Inc
107.66%
7.14%
-28.19%
-98.56%
-98.19%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-17.98%
-13.74%
0.21%
32.39%
141.22%
Biontech Se
Biontech Se
-10.32%
19.69%
8.29%
-55.53%
471.7%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
0.38%
78.75%
60.7%
44.82%
192.62%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
9.48%
19.97%
33.29%
161.38%
149.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Allakos Inc
Allakos Inc
NA
NA
NA
-1.54
-1.22
-0.49
NA
0.95
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
20.53
20.53
1.2
44.89
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-1.87
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.27
0.19
-0.03
0.13
NA
60.66
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Allakos Inc
Allakos Inc
Buy
$125.3M
-98.19%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$91.1B
141.22%
20.53
33.61%
Biontech Se
Biontech Se
Buy
$25.6B
471.7%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$35.2B
192.62%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.9B
149.59%
32.84
-4.51%

Insights on Allakos Inc

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.7% return, outperforming this stock by 88.9%

  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 44.8% return, outperforming this stock by 143.4%

Institutional Holdings

  • Bvf Inc

    18.63%
  • NEA Management Company, LLC

    6.92%
  • Logos Global Management LP

    6.53%
  • Deep Track Capital, LP

    5.63%
  • FMR Inc

    5.27%
  • Morgan Stanley - Brokerage Accounts

    3.99%

Company Information

allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.

Organization
Allakos Inc
Employees
131
CEO
Dr. Robert Alexander Ph.D.
Industry
Health Technology

FAQs